38OTalazoparib (TALA) vs physician’s choice of chemotherapy...

Annals of Oncology 2019 / 11 Vol. 30; Iss. Supplement

38OTalazoparib (TALA) vs physician’s choice of chemotherapy (PCT) in Asian patients (Pts) with HER2- advanced breast cancer (ABC) and a germline BRCA1/2 mutation (gBRCA1/2mut): Data from phase III EMBRACA

Lee, K-H, Kim, S-B, Sohn, J, Goodwin, A, Usari, T, Lanzalone, S, Im, Y-H
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz418.001
Date:
November, 2019
File:
PDF, 84 KB
2019
Conversion to is in progress
Conversion to is failed